Zagozdzon et al., 2022 - Google Patents
Immune evasion as the main challenge for immunotherapy of cancerZagozdzon et al., 2022
View PDF- Document ID
- 13048661155216680230
- Author
- Zagozdzon R
- Winiarska M
- Firczuk M
- Publication year
- Publication venue
- Cancers
External Links
Snippet
Immune evasion is currently considered one of the most prominent hallmarks of cancer [1]. The immune system has evolved to perform two main functions:(1) elimination of the pathogenic danger and (2) tolerance toward self-tissues or symbiotic organisms …
- 201000011510 cancer 0 title abstract description 34
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zagozdzon et al. | Immune evasion as the main challenge for immunotherapy of cancer | |
| Yang et al. | B7-H3, a checkpoint molecule, as a target for cancer immunotherapy | |
| Fehlings et al. | Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells | |
| Danilova et al. | Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors | |
| Bartmann et al. | Evaluation of riboflavin transporters as targets for drug delivery and theranostics | |
| Bae et al. | The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients | |
| Liebl et al. | Identification of responders to immune checkpoint therapy: which biomarkers have the highest value? | |
| Mazloom et al. | Marginal zone lymphomas: factors that affect the final outcome | |
| Huang et al. | Cu (II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis | |
| Wang et al. | Biomimetic nanophotosensitizer amplifies immunogenic pyroptosis and triggers synergistic cancer therapy | |
| Dharmasiri et al. | Differential ion mobility spectrometry coupled to tandem mass spectrometry enables targeted leukemia antigen detection | |
| Li et al. | Tandem‐Mass‐Tag Based Proteomic Analysis Facilitates Analyzing Critical Factors of Porous Silicon Nanoparticles in Determining Their Biological Responses under Diseased Condition | |
| EP1377596A4 (en) | Ttk in diagnosis and as a therapeutic target in cancer | |
| Yu et al. | A five‐gene signature is a prognostic biomarker in pan‐cancer and related with immunologically associated extracellular matrix | |
| Kusuda et al. | Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature | |
| Liu et al. | One‐Step Symbiosis of Bimetallic Peroxides Nanoparticles to Induce Ferroptosis/Cuproptosis and Activate cGAS‐STING Pathway for Enhanced Tumor Immunotherapy | |
| Marsh et al. | Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis | |
| Mateusiak et al. | Generation and characterization of novel Pan‐cancer anti‐uPAR fluorescent nanobodies as tools for image‐guided surgery | |
| Yang et al. | Anti-PD-L1 nanobody guided in situ self-assembly and release of IOX1 and FDU for enhanced cancer chemo-immunotherapy | |
| Torabi Farkhani et al. | Evaluation of N—H⋯ S and N—H⋯ π interactions in O, O′-diethyl N-(2, 4, 6-trimethylphenyl) thiophosphate: a combination of X-ray crystallographic and theoretical studies | |
| Adeberg et al. | Intensity modulated radiotherapy (IMRT) with carbon ion boost in the multimodal treatment of salivary duct carcinoma | |
| Zhao et al. | Molecular docking, 3D-QASR and molecular dynamics simulations of thiazoles Pin1 inhibitors | |
| Uskent et al. | Prognostic significance of tumor tissue NeuGcGM3 ganglioside expression in patients receiving racotumomab immunotherapy | |
| Wang et al. | Quantitative systems pharmacology modeling of macrophage‐targeted therapy combined with PD‐L1 inhibition in advanced NSCLC | |
| Wang et al. | A CLDN18. 2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer |